BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3291522)

  • 21. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical treatment of neuroendocrine tumours of the pancreas].
    Farkas G
    Magy Onkol; 2003; 47(4):345-7. PubMed ID: 14716428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of patients with non-functioning gastroentero-pancreatic neuroendocrine tumours].
    Guarnieri A; Tirone A; Pallucca E; Testa M; Piccolomini A; Vuolo G; Savelli V; Di Cosmo L; Verre L; Carli AF
    Chir Ital; 2006; 58(3):389-96. PubMed ID: 16845879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
    Tsimmerman IaS
    Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas.
    Soga J; Yakuwa Y
    J Exp Clin Cancer Res; 1999 Mar; 18(1):13-22. PubMed ID: 10374671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
    Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
    Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastric carcinoid--pathogenesis and treatment].
    Bründler R; Gebbers JO; Criblez D
    Schweiz Med Wochenschr; 1999 Jun; 129(25):945-50. PubMed ID: 10422189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic neuroendocrine tumours.
    Alexakis N; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience.
    Tonelli F; Fratini G; Falchetti A; Nesi G; Brandi ML
    J Intern Med; 2005 Jan; 257(1):38-49. PubMed ID: 15606375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual peptide-secreting tumors in adolescents and children.
    Schwartz MZ
    Semin Pediatr Surg; 1997 Aug; 6(3):141-6. PubMed ID: 9263336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
    Plöckinger U; Wiedenmann B
    Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical aspects of carcinoid tumours.
    Tomassetti P
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S143-6. PubMed ID: 10604119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
    Arnold R
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.
    Norton JA
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):577-83. PubMed ID: 16183528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastrin-producing tumors (gastrinomas) of the pancreas].
    Orlov VA
    Klin Med (Mosk); 1973 Oct; 51(10):14-9. PubMed ID: 4787275
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment strategy of neuroendocrine tumors].
    Ducreux M; Baudin E; Schlumberger M
    Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diffuse endocrine-paracrine system of the gut in health and disease: ultrastructural features.
    Solcia E; Capella C; Buffa R; Usellini L; Fiocca R; Frigerio B; Tenti P; Sessa F
    Scand J Gastroenterol Suppl; 1981; 70():25-36. PubMed ID: 6118945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoid tumour.
    McStay MK; Caplin ME
    Minerva Med; 2002 Oct; 93(5):389-401. PubMed ID: 12410171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of intestinal carcinoids.
    Angeletti S; Annibale B; Marignani M; Corleto VD; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S108-10. PubMed ID: 10604113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.